2 completed, 2 terminated, 1 recruiting. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Terminated 2, Recruiting 1 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow Mixed Connective Tissue Disease: new trials by email Literature Review of Mixed Connective Tissue Disease trials Research Report on Mixed Connective Tissue Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intralesional Injection of STS in Treatment of Calcinosis Sodium Thiosulfate (STS) - Systemic Sclerosis (SSc), Dermatomyositis | Phase 2 | Recruiting | Robyn T. Domsic, MD, MPH | 20 | 2025-03-17 | 2026-05-05 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) MHV370, Placebo - Sjogren Syndrome, Mixed Connective Tissue Disease | Phase 2 | Terminated | Novartis Pharmaceuticals | 30 | 2021-11-30 | 2024-10-09 |
| Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD Rituximab, Cyclophosphamide - Interstitial Lung Disease, Scleroderma | Phase 2 / Phase 3 | Completed | Royal Brompton & Harefield NHS Foundation Trust | 104 | 2014-11-01 | 2021-10-07 |
| A Clinical Trial for CTD-ILD Treatment N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease | Phase 2 / Phase 3 | Terminated | University of Michigan | 5 | 2011-12-01 | 2017-04-06 |
| Alendronate Osteoporosis Study Alendronate - Glucocorticoid-Associated Osteopenia and Osteoporosis | Phase 2 / Phase 3 | Completed | Boston Children's Hospital | 20 | 2003-03-01 | 2017-04-11 |
Dermatomyositis (4) · Connective Tissue Diseases (2) · Lung Diseases, Interstitial (2) · Polymyositis (2) · Scleroderma, Diffuse (2) · Sjogren's Syndrome (2) · Arthritis, Juvenile (1) · Arthritis, Rheumatoid (1) · Calcinosis (1) · Crohn Disease (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Osteoporosis (1) · Pulmonary Fibrosis (1)
Musculoskeletal Diseases (5) · Skin and Connective Tissue Diseases (5) · Muscular Diseases (4) · Nervous System Diseases (4) · Neuromuscular Diseases (4) · Skin Diseases (4) · Arthritis (3) · Autoimmune Diseases (3) · Connective Tissue Diseases (3) · Immune System Diseases (3) · Joint Diseases (3) · Myositis (3) · Rheumatic Diseases (3) · Dry Eye Syndromes (2) · Eye Diseases (2)
Acetylcysteine (1) · Alendronate (1) · Cyclophosphamide (1) · Rituximab (1) · sodium thiosulfate (1)
Boston Children's Hospital (1) · Novartis Pharmaceuticals (1) · Robyn T. Domsic, MD, MPH (1) · Royal Brompton & Harefield NHS Foundation Trust (1) · University of Michigan (1)
United States (2) · China (1) · Germany (1) · Hungary (1) · Poland (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Catherine Gordon, MD (1) · Robyn T Domsis, MD (1) · Toby M Maher, MD PhD (1)
PMID 15942915, PMID 22227955, PMID 28619061, PMID 36375479, PMID 40747756, PMID 40787733
P50AR080612 (1)